Thanks to our close relationship with vendors and manufacturers, we have the unique capability to find niche products and hard to find medicines. You can rely on us for getting the newest approved products in the market and those not yet available in some countries. Our range of products is so wide, you won’t need to look for other suppliers.
with a wide clients’ base made of hospitals, private clinics, pharmacies and distributors, we have developed a deep knowledge of what the needs, constraints and priorities are for each or our client. That is why we understand your urgency and we can fully meet your demands with the highest standards of service.
Our stringent operating procedures guarantee every step of handling, storage and distribution of all medicinal products.
When you contact us in Elixi, you know you are getting the best customer service: our dedicated people will offer you quick responses, personalised approach and bespoke solutions. Our approach is not to follow only standard procedures but taking care of every specific detail and taking to heart every request and individual issues.
Mavyret (glecaprevir and pibrentasvir) tablets, have now been approved by the FDA for an eight-week duration for the treatment of
The U.S. Food and Drug Administration has approved Rybelsus (semaglutide) oral tablets to improve control of blood sugar in adult
The U.S. Food and Drug Administration has approved Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function
The U.S. Food and Drug Administration has approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients
The U.S. Food and Drug Administration has approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia. “This new drug
The U.S. Food and Drug Administration has approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.
Vicolo Oldelli 1
6830 Chiasso / Switzerland
Email info@elixi-int.com
Phone/Fax +41 91 6822040
